Pemphigus Vulgaris (PV) is a life-threatening autoimmune disease manifested with blisters in the skin and mucosa and caused by autoantibodies against adhesion protein desmoglein-3 (Dsg3) expressed in epithelial membrane linings of these tissues. Despite many studies, the pathogenesis of PV remains incompletely understood. Recently we have shown Dsg3 plays a role in regulating the yes-associated protein (YAP), a co-transcription factor and mechanical sensor, and constraining reactive oxygen species (ROS). This study investigated the effect of PV sera as well as the anti-Dsg3 antibody AK23 on these molecules. We detected elevated YAP steady-state protein levels in PV cells surrounding blisters and perilesional regions and in keratinocytes treated with PV sera and AK23 with concomitant transient ROS overproduction. Cells treated with hydrogen peroxide also exhibited augmented nuclear YAP accompanied by reduction of Dsg3 and α-catenin, a negative regulator of YAP. As expected, transfection of α-catenin-GFP plasmid rendered YAP export from the nucleus evoked by hydrogen peroxide. In addition, suppression of total YAP was observed in hydrogen peroxide treated cells exposed to antioxidants with enhanced cell-cell adhesion being confirmed by decreased fragmentation in the dispase assay compared to hydrogen peroxide treatment alone. On the other hand, the expression of exogenous YAP disrupted intercellular junction assembly. In contrast, YAP depletion resulted in an inverse effect with augmented expression of junction assembly proteins, including Dsg3 and α-catenin capable of abolishing the effect of AK23 on Dsg3 expression. Finally, inhibition of other kinase pathways, including p38MAPK, also demonstrated suppression of YAP induced by hydrogen peroxide. Furthermore, antioxidant treatment of keratinocytes suppressed PV sera-induced total YAP accumulation. In conclusion, this study suggests that oxidative stress coupled with YAP dysregulation attributes to PV blistering, implying antioxidants may be beneficial in the treatment of PV.

CB Joint MHNCRL Hospital and School of Stomatology Guizhou Medical University Guiyang China

Centre for Oral Immunobiology and Regenerative Medicine Institute of Dentistry Barts and The London School of Medicine and Dentistry London United Kingdom

Department of Dermatology St Anna University Hospital Brno Czechia

Phenotypic Screening Facility Blizard Institute Barts and The London School of Medicine and Dentistry London United Kingdom

Zobrazit více v PubMed

Amagai M. Autoimmune and infectious skin diseases that target desmogleins. Proc Jpn Acad Ser B Phys Biol Sci (2010) 86:524–37. 10.2183/pjab.86.524 PubMed DOI PMC

Kitajima Y. 150(th) anniversary series: Desmosomes and autoimmune disease, perspective of dynamic desmosome remodeling and its impairments in pemphigus. Cell Commun Adhes (2014) 21:269–80. 10.3109/15419061.2014.943397 PubMed DOI

Lanza A, Cirillo N, Femiano F, Gombos F. How does acantholysis occur in pemphigus vulgaris: a critical review. J Cutan Pathol (2006) 33:401–12. 10.1111/j.0303-6987.2006.00523.x PubMed DOI

Waschke J. The desmosome and pemphigus. Histochem Cell Biol (2008) 130:21–54. 10.1007/s00418-008-0420-0 PubMed DOI PMC

Spindler V, Eming R, Schmidt E, Amagai M, Grando S, Jonkman MF, et al. . Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus. J Invest Dermatol (2018) 138:32–7. 10.1016/j.jid.2017.06.022 PubMed DOI

Heupel WM, Zillikens D, Drenckhahn D, Waschke J. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. J Immunol (2008) 181:1825–34. 10.4049/jimmunol.181.3.1825 PubMed DOI

Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T, et al. . Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol (2003) 170:2170–8. 10.4049/jimmunol.170.4.2170 PubMed DOI

Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley JR. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest (1992) 90:919–26. 10.1172/JCI115968 PubMed DOI PMC

Caldelari R, de Bruin A, Baumann D, Suter MM, Bierkamp C, Balmer V, et al. . A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol (2001) 153:823–34. 10.1083/jcb.153.4.823 PubMed DOI PMC

Kawasaki Y, Aoyama Y, Tsunoda K, Amagai M, Kitajima Y. Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line. Autoimmunity (2006) 39:587–90. 10.1080/08916930600971943 PubMed DOI

Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP, et al. . Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem (2005) 280:23778–84. 10.1074/jbc.M501365200 PubMed DOI

Vielmuth F, Waschke J, Spindler V. Loss of Desmoglein Binding Is Not Sufficient for Keratinocyte Dissociation in Pemphigus. J Invest Dermatol (2015) 135:3068–77. 10.1038/jid.2015.324 PubMed DOI

Mao X, Sano Y, Park JM, Payne AS. p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris. J Biol Chem (2011) 286:1283–91. 10.1074/jbc.M110.172874 PubMed DOI PMC

Spindler V, Waschke J. Role of Rho GTPases in desmosomal adhesion and pemphigus pathogenesis. Ann Anat (2011) 193:177–80. 10.1016/j.aanat.2011.02.003 PubMed DOI

Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, Posthaus H, et al. . Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J (2006) 25:3298–309. 10.1038/sj.emboj.7601224 PubMed DOI PMC

Tsang SM, Brown L, Lin K, Liu L, Piper K, O’Toole EA, et al. . Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris. J Pathol (2012) 227:81–93. 10.1002/path.3982 PubMed DOI

Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem (2007) 282:13804–12. 10.1074/jbc.M611365200 PubMed DOI

Marchenko S, Chernyavsky AI, Arredondo J, Gindi V, Grando SA. Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. J Biol Chem (2010) 285:3695–704. 10.1074/jbc.M109.081570 PubMed DOI PMC

Grando SA. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity (2012) 45:7–35. 10.3109/08916934.2011.606444 PubMed DOI PMC

Sinha AA, Sajda T. The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the “Super Compensation Hypothesis”. Front Med (Lausanne) (2018) 5:218. 10.3389/fmed.2018.00218 PubMed DOI PMC

Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest (2000) 106:1467–79. 10.1172/JCI10305 PubMed DOI PMC

Zhu C, Li L, Zhao B. The regulation and function of YAP transcription co-activator. Acta Biochim Biophys Sin (Shanghai) (2015) 47:16–28. 10.1093/abbs/gmu110 PubMed DOI

Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev (2014) 94:1287–312. 10.1152/physrev.00005.2014 PubMed DOI

Aqeilan RI. Hippo signaling: to die or not to die. Cell Death Differ (2013) 20:1287–8. 10.1038/cdd.2013.100 PubMed DOI PMC

Yu FX, Zhao B, Guan KL. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell (2015) 163:811–28. 10.1016/j.cell.2015.10.044 PubMed DOI PMC

Shao D, Zhai P, Del Re DP, Sciarretta S, Yabuta N, Nojima H, et al. . A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun (2014) 5:3315. 10.1038/ncomms4315 PubMed DOI PMC

Chen SN, Gurha P, Lombardi R, Ruggiero A, Willerson JT, Marian AJ. The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy. Circ Res (2014) 114:454–68. 10.1161/CIRCRESAHA.114.302810 PubMed DOI PMC

Plouffe SW, Hong AW, Guan KL. Disease implications of the Hippo/YAP pathway. Trends Mol Med (2015) 21:212–22. 10.1016/j.molmed.2015.01.003 PubMed DOI PMC

Uttagomol J, Ahmad US, Rehman A, Huang Y, Laly AC, Kang A, et al. . Evidence for the Desmosomal Cadherin Desmoglein-3 in Regulating YAP and Phospho-YAP in Keratinocyte Responses to Mechanical Forces. Int J Mol Sci (2019) 20(24):6221. 10.1101/827725 PubMed DOI PMC

Shah AA, Dey-Rao R, Seiffert-Sinha K, Sinha AA. Increased oxidative stress in pemphigus vulgaris is related to disease activity and HLA-association. Autoimmunity (2016) 49:248–57. 10.3109/08916934.2016.1145675 PubMed DOI

Javanbakht MH, Djalali M, Daneshpazhooh M, Zarei M, Eshraghian MR, Derakhshanian H, et al. . Evaluation of antioxidant enzyme activity and antioxidant capacity in patients with newly diagnosed pemphigus vulgaris. Clin Exp Dermatol (2015) 40:313–7. 10.1111/ced.12489 PubMed DOI

Yesilova Y, Ucmak D, Selek S, Dertlioglu SB, Sula B, Bozkus F, et al. . Oxidative stress index may play a key role in patients with pemphigus vulgaris. J Eur Acad Dermatol Venereol (2013) 27:465–7. 10.1111/j.1468-3083.2012.04463.x PubMed DOI

Abida O, Gargouri B, Ben MR, Mseddi-Djemal M, Masmoudi A, Ben AM, et al. . Biomarkers of oxidative stress in epidermis of Tunisian pemphigus foliaceus patients. J Eur Acad Dermatol Venereol (2013) 27:e271–5. 10.1111/j.1468-3083.2012.04626.x PubMed DOI

Mao B, Gao Y, Bai Y, Yuan Z. Hippo signaling in stress response and homeostasis maintenance. Acta Biochim Biophys Sin (Shanghai) (2015) 47:2–9. 10.1093/abbs/gmu109 PubMed DOI

Dixit D, Ghildiyal R, Anto NP, Sen E. Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism. Cell Death Dis (2014) 5:e1212. 10.1038/cddis.2014.179 PubMed DOI PMC

Roh KH, Choi EJ. TRAF2 functions as an activator switch in the reactive oxygen species-induced stimulation of MST1. Free Radic Biol Med (2016) 91:105–13. 10.1016/j.freeradbiomed.2015.12.010 PubMed DOI

Rehman A, Cai Y, Hunefeld C, Jedlickova H, Huang Y, Teck TM, et al. . The desmosomal cadherin desmoglein-3 acts as a keratinocyte anti-stress protein via suppression of p53. Cell Death Dis (2019) 10:750. 10.1038/s41419-019-1988-0 PubMed DOI PMC

Li X, Ahmad US, Huang Y, Uttagomol J, Rehman A, Zhou K, et al. . Desmoglein-3 acts as a pro-survival protein by suppressing reactive oxygen species and doming whilst augmenting the tight junctions in MDCK cells. Mech Ageing Dev (2019) 184:111174. 10.1016/j.mad.2019.111174 PubMed DOI

Rheinwald JG, Hahn WC, Ramsey MR, Wu JY, Guo Z, Tsao H, et al. . A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol Cell Biol (2002) 22:5157–72. 10.1128/MCB.22.14.5157-5172.2002 PubMed DOI PMC

Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, et al. . Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol (2000) 20:1436–47. 10.1128/MCB.20.4.1436-1447.2000 PubMed DOI PMC

Moftah H, Dias K, Apu EH, Liu L, Uttagomol J, Bergmeier L, et al. . Desmoglein 3 regulates membrane trafficking of cadherins, an implication in cell-cell adhesion. Cell Adh Migr (2016) 11(3):211–32. 10.1080/19336918.2016.1195942 PubMed DOI PMC

Jennings JM, Tucker DK, Kottke MD, Saito M, Delva E, Hanakawa Y, et al. . Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous dsg3. J Invest Dermatol (2011) 131:706–18. 10.1038/jid.2010.389 PubMed DOI PMC

Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, et al. . Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell (2011) 144:782–95. 10.1016/j.cell.2011.02.031 PubMed DOI PMC

Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci U S A (2011) 108:11930–5. 10.1073/pnas.1103345108 PubMed DOI PMC

Abe-Yutori M, Chikazawa T, Shibasaki K, Murakami S. Decreased expression of E-cadherin by Porphyromonas gingivalis-lipopolysaccharide attenuates epithelial barrier function. J Periodontal Res (2017) 52:42–50. 10.1111/jre.12367 PubMed DOI

Inumaru J, Nagano O, Takahashi E, Ishimoto T, Nakamura S, Suzuki Y, et al. . Molecular mechanisms regulating dissociation of cell-cell junction of epithelial cells by oxidative stress. Genes Cells (2009) 14:703–16. 10.1111/j.1365-2443.2009.01303.x PubMed DOI

Kim KA, Jung JH, Kang IG, Choi YS, Kim ST. ROS Is Involved in Disruption of Tight Junctions of Human Nasal Epithelial Cells Induced by HRV16. Laryngoscope (2018) 128:E393–401. 10.1002/lary.27510 PubMed DOI

Narimatsu T, Ozawa Y, Miyake S, Kubota S, Hirasawa M, Nagai N, et al. . Disruption of cell-cell junctions and induction of pathological cytokines in the retinal pigment epithelium of light-exposed mice. Invest Ophthalmol Vis Sci (2013) 54:4555–62. 10.1167/iovs.12-11572 PubMed DOI

Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell (2001) 104:605–17. 10.1016/S0092-8674(01)00246-X PubMed DOI

Wan H. Desmoglein-3. In: Choi S, editor. Encyclopedia of Signaling Molecules. New York, NY: Springer New York; (2016). p. 1–15. 10.1007/978-1-4614-6438-9_101583-1 DOI

Ahmed AR, Carrozzo M, Caux F, Cirillo N, Dmochowski M, Alonso AE, et al. . Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology. Exp Dermatol (2016) 25:839–46. 10.1111/exd.13106 PubMed DOI

Lee HB, Yu MR, Song JS, Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int (2004) 65:1170–9. 10.1111/j.1523-1755.2004.00491.x PubMed DOI

Sato A, Okada M, Shibuya K, Watanabe E, Seino S, Narita Y, et al. . Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells. Stem Cell Res (2014) 12:119–31. 10.1016/j.scr.2013.09.012 PubMed DOI

Son Y, Cheong YK, Kim NH, Chung HT, Kang DG, Pae HO. Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways? J Signal Transduction (2011) 2011:792639. 10.1155/2011/792639 PubMed DOI PMC

Son Y, Kim S, Chung HT, Pae HO. Reactive oxygen species in the activation of MAP kinases. Methods Enzymol (2013) 528:27–48. 10.1016/B978-0-12-405881-1.00002-1 PubMed DOI

Wang Y, Bell JC, Keeney DS, Strobel HW. Gene regulation of CYP4F11 in human keratinocyte HaCaT cells. Drug Metab Dispos (2010) 38:100–7. 10.1124/dmd.109.029025 PubMed DOI PMC

Brown L, Waseem A, Cruz IN, Szary J, Gunic E, Mannan T, et al. . Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation. Oncogene (2014) 33:2363–74. 10.1038/onc.2013.186 PubMed DOI

Panciera T, Azzolin L, Cordenonsi M, Piccolo S. Mechanobiology of YAP and TAZ in physiology and disease. Nat Rev Mol Cell Biol (2017) 18:758–70. 10.1038/nrm.2017.87 PubMed DOI PMC

Tsang SM, Liu L, Teh MT, Wheeler A, Grose R, Hart IR, et al. . Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src. PloS One (2010) 5:e14211. 10.1371/journal.pone.0014211 PubMed DOI PMC

Williamson L, Suter MM, Olivry T, Wyder M, Muller EJ. Upregulation of c-Myc may contribute to the pathogenesis of canine pemphigus vulgaris. Vet Dermatol (2007) 18:12–7. 10.1111/j.1365-3164.2007.00561.x PubMed DOI

Berkowitz P, Chua M, Liu Z, Diaz LA, Rubenstein DS. Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin. Am J Pathol (2008) 173:1628–36. 10.2353/ajpath.2008.080391 PubMed DOI PMC

Jolly PS, Berkowitz P, Bektas M, Lee HE, Chua M, Diaz LA, et al. . p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. J Biol Chem (2010) 19(285):8936–41. 10.1074/jbc.M109.087999 PubMed DOI PMC

Lin KC, Moroishi T, Meng Z, Jeong HS, Plouffe SW, Sekido Y, et al. . Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation. Nat Cell Biol (2017) 19:996–1002. 10.1038/ncb3581 PubMed DOI PMC

Takaguri A, Kubo T, Mori M, Satoh K. The protective role of YAP1 on ER stress-induced cell death in vascular smooth muscle cells. Eur J Pharmacol (2017) 815:470–7. 10.1016/j.ejphar.2017.09.033 PubMed DOI

Budanov AV. The role of tumor suppressor p53 in the antioxidant defense and metabolism. Subcell Biochem (2014) 85:337–58. 10.1007/978-94-017-9211-0_18 PubMed DOI PMC

van WS, van Buul JD, Quik S, Mul FP, Anthony EC, ten Klooster JP, et al. . Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci (2002) 115:1837–46. PubMed

Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol (2001) 280:C719–41. 10.1152/ajpcell.2001.280.4.C719 PubMed DOI

Egu DT, Sigmund AM, Schmidt E, Spindler V, Walter E, Waschke J. A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody-induced mucosal blistering in pemphigus. Br J Dermatol (2020) 182:987–94. 10.1111/bjd.18237 PubMed DOI